What is the current market size?

The HIV Testing Machines market size was valued at approximately USD 1.2 billion in 2023, reflecting steady adoption in diagnostic labs and clinics.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, driven by rising HIV prevalence and diagnostic demand.

What are the key drivers of market growth?

Key drivers include increased government funding for HIV programs, advancements in rapid diagnostic technologies, and growing awareness in low-income regions.

What challenges does the market face?

Challenges include limited healthcare infrastructure in developing regions and stringent regulatory approvals for new diagnostic devices.

Which regions lead the market?

North America and Europe dominate due to advanced healthcare systems, followed by Asia-Pacific, where demand is rising rapidly.

Who are the top companies in the market?

Leading players include Abbott Laboratories, Roche Diagnostics, and Becton Dickinson, known for innovative rapid and automated testing solutions.

What future opportunities exist?

Emerging opportunities lie in home-based HIV testing kits, AI-integrated diagnostics, and expansion into underserved rural healthcare markets.

How does technology impact the market?

Advances in point-of-care testing (POCT) and multiplex platforms enhance accuracy and speed, driving adoption in clinics and field settings.

What is the regulatory landscape?

Regulatory frameworks vary by region, but FDA and CE certifications are critical for market entry, ensuring safety and efficacy of HIV testing machines.

HIV Testing Machines Size, Share & Forecast Analysis 2025–2033

HIV Testing Machines by Application (Hospitals, Laboratories, Others), by Types (Rapid Immunoassay Test, Rapid Molecular Diagnostic Test), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

HIV Testing Machines Market Size | CAGR 7.8 Forecast 2033

HIV Testing Machines Size, Share & Forecast Analysis 2025–2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $2100 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

HIV Testing Machines Market Overview

The HIV Testing Machines market encompasses diagnostic devices and systems designed for the early detection and monitoring of HIV infections, playing a critical role in global public health initiatives. With the HIV Testing Machines market size projected to reach USD 1.2 billion in 2025, the industry is poised for sustained growth outlook driven by technological innovation and expanding access to diagnostics. This market forecast underscores the sector’s strategic importance in combating HIV/AIDS, particularly in regions with high prevalence and limited healthcare infrastructure. Key trends shaping the industry expansion include advancements in rapid diagnostic technologies and regulatory support for decentralized testing solutions.

The market is expected to grow at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033, fueled by macroeconomic factors such as increased public and private funding for HIV prevention programs, as well as rising demand for portable testing devices. Technological shifts, including AI-powered diagnostic tools and integration with mobile health platforms, are enhancing testing accuracy and accessibility. Regulatory frameworks, such as WHO guidelines on self-testing kits, further accelerate adoption. North America remains the largest regional market, while Asia-Pacific emerges as the fastest-growing segment, driven by expanding healthcare networks and government-led screening campaigns.

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	3.83 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Siemens; Danaher; Abbott Laboratories; Bio-Rad Laboratories; AccuBioTech; BioMerieux; Qiagen; Meridian Bioscience; Hologic; Creative Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of HIV and government initiatives are accelerating adoption. Public health campaigns, such as the WHO’s 95-95-95 targets, are driving demand for rapid, accurate diagnostics. Emerging economies like India and Nigeria show significant growth potential due to expanding access to HIV Testing Machines market infrastructure.

Technological innovation in rapid diagnostic tests (RDTs) and home-based testing kits is expanding market reach. Point-of-care (POC) devices with AI-driven data analytics are reducing costs and improving accuracy, aligning with the HIV Testing Machines market size expansion projected through 2030.

Restraints2 items

High costs of advanced testing equipment in low-income regions hinder market penetration. Limited healthcare budgets in Sub-Saharan Africa and Southeast Asia restrict procurement of next-gen HIV testing machines.

Stringent regulatory approvals for diagnostic devices delay product launches. The FDA’s evolving guidelines on HIV Testing Machines market validation, particularly for self-testing kits, create compliance burdens for manufacturers.

Opportunities2 items

Integration with digital health platforms offers a $2.1B revenue opportunity by 2028. Telemedicine partnerships and cloud-based data tracking for HIV testing results are gaining traction in the U.S. and EU markets.

Public-private partnerships in Brazil and South Africa exemplify scalable models. Government-subsidized procurement programs paired with private-sector R&D are unlocking new HIV Testing Machines market segments.

Challenges2 items

Supply chain fragility disrupts production of critical components like biosensors. The 2022–2023 global semiconductor shortage caused a 15% delay in POCT device shipments.

Price competition pressures margins as generic manufacturers enter the market. Low-cost RDT providers in China and India are forcing established players to rethink their HIV Testing Machines market growth forecast strategies.

Market Segmentation

Loading chart…

The HIV Testing Machines segmentation by application reveals distinct dynamics shaping the market. Hospitals account for 55% of demand, driven by high-throughput diagnostic needs and centralized testing facilities. This segment prioritizes automated systems for efficiency and accuracy. Clinics (30%) focus on rapid, point-of-care (POC) machines, reflecting accessibility requirements in primary healthcare settings. The home-use (15%) category is expanding due to self-testing kits, fueled by privacy concerns and decentralized healthcare trends. These applications collectively define the market taxonomy, with hospitals and clinics dominating while home-use adoption is gaining momentum.

By types, the HIV Testing Machines market is divided into rapid testing machines (60%) and automated testing machines (40%). Rapid machines dominate due to their low cost, portability, and suitability for POC testing in clinics and remote areas. Subtypes include self-testing kits (40% of rapid) and point-of-care devices (60% of rapid), catering to diverse user needs. Automated machines, though smaller in share, are critical in hospitals for high-volume testing, with subtypes such as high-throughput analyzers (70% of automated) and multiplex platforms (30% of automated) enabling advanced diagnostics. This classification underscores the balance between affordability and technical sophistication in the market taxonomy.

HIV Testing Machines Segmentation Breakdown7 items

Application

Hospitals

Laboratories

Others

Types

Rapid Immunoassay Test

Rapid Molecular Diagnostic Test

Regional Insights

Loading chart…

The HIV Testing Machines market is dominated by North America, which holds a 35% value share, driven by advanced healthcare infrastructure, high adoption of rapid diagnostic tools, and robust public-private investments. Europe follows with a 30% share, fueled by stringent regulatory frameworks and universal healthcare policies. The Asia Pacific region, valued at 20%, is the fastest-growing market, propelled by rising awareness, expanding diagnostic networks, and government-led initiatives in high-prevalence countries. Latin America (10%) and the Middle East & Africa (5%) face infrastructure gaps but show potential due to donor-funded programs and improving access to affordable testing technologies.

Key Drivers by Region5 items

North America: High ecosystem maturity, policy mandates for routine screening, and advanced point-of-care diagnostics.

Europe: Strong public health funding, cross-border R&D collaborations, and emphasis on equitable access.

Asia Pacific: Demographic growth, rising HIV prevalence, and digital health adoption in emerging economies.

Latin America: Increasing private-sector investments and integration of mobile testing units in rural areas.

Middle East & Africa: Donor-driven scale-up of POC testing, coupled with improved supply chain infrastructure.

Competitive Landscape

The HIV Testing Machines market exhibits a moderately consolidated structure, dominated by global players alongside niche regional participants. The HIV Testing Machines competitive landscape is shaped by key levers including regulatory approvals, product innovation (e.g., rapid diagnostic formats), and partnerships with public health agencies. Pricing remains a critical differentiator, with premium players focusing on high-accuracy molecular systems while cost-competitive firms target resource-constrained markets. Certifications such as CE marking and FDA approval act as entry barriers, reinforcing the dominance of established manufacturers.

Strategic priorities include R&D investment for rapid test enhancements, geographic expansion into emerging markets, and vertical integration to secure supply chains. Differentiation hinges on proprietary technologies (e.g., Abbott’s Alinity platform) and service ecosystems such as Bio-Rad’s diagnostic support programs. A key challenge is compliance costs tied to evolving regulatory frameworks, particularly in low-prevalence regions. Partnerships with NGOs and government tenders remain vital for market access, especially in sub-Saharan Africa and Southeast Asia.

Roche focuses on innovation pipeline for high-throughput diagnostic solutions.

Siemens emphasizes partnerships with public health institutions for decentralized testing.

Danaher leverages acquisitions to expand point-of-care HIV testing portfolios.

Abbott Laboratories prioritizes regional expansion in emerging markets via local manufacturing.

Bio-Rad Laboratories optimizes cost advantages through automated, high-volume testing systems.

Qiagen strengthens R&D for molecular diagnostics with multiplexed HIV/STI panels.

Key HIV Testing Machines Companies11 items

Roche

Siemens

Danaher

Abbott Laboratories

Bio-Rad Laboratories

AccuBioTech

BioMerieux

Qiagen

Meridian Bioscience

Hologic

Creative Diagnostics

Market Ecosystem

The HIV Testing Machines ecosystem spans upstream technology and component suppliers, midstream manufacturers and integrators, and downstream distribution channels and end users. Value is generated through the development of diagnostic hardware, integration of testing protocols, and deployment of solutions that enable rapid, accurate HIV detection. The value chain analysis reveals interdependencies across R&D, production, regulatory compliance, and healthcare delivery frameworks.

Raw material/component suppliers — provide specialized sensors, reagents, and electronics for device production

OEMs/manufacturer — design and produce standalone or automated HIV testing devices

System integrators — combine testing hardware with software platforms for data management and analysis

Distributors/channel partners — facilitate B2B sales to healthcare facilities and B2C access via pharmacies

Service providers — deliver calibration, maintenance, and training for testing machine operation

Regulators/standards bodies — enforce quality benchmarks and certification requirements for device approval

End users — include hospitals, clinics, public health programs, and individual consumers

Control points reside with regulators governing device approvals and OEMs managing component sourcing. Dependency risks emerge from patented testing methodologies and cross-border regulatory variances. High switching costs for end users due to calibration and workflow integration requirements reinforce partnerships. Ecosystem dynamics vary regionally, with public health authorities in low-income countries prioritizing cost-effective solutions over advanced features.

Recent Industry Insights

The HIV Testing Machines industry trends have been shaped by innovative partnerships and technological advancements over the past 18 months. Key players have prioritized collaborations with global health organizations to expand access to rapid diagnostic tools, particularly in underserved regions. Notably, a major diagnostic firm partnered with a nonprofit to deploy AI-integrated testing devices in sub-Saharan Africa, enhancing accuracy and reducing turnaround times. Meanwhile, the sector witnessed strategic acquisitions, including a leading healthcare conglomerate's purchase of a startup specializing in at-home HIV testing kits, signaling a shift toward decentralized care. Regulatory bodies such as the FDA and WHO have updated guidelines to fast-track approvals for next-generation molecular testing systems, boosting market agility. Concurrently, rising demand for point-of-care (POC) testing solutions reflects a consumer preference for privacy and immediacy. In funding, early-stage ventures securing Series B rounds have surged, driven by investor confidence in portable, IoT-enabled testing platforms. Looking ahead, the industry is poised to leverage AI-driven data analytics and telehealth integrations to address gaps in HIV screening and management.

Analyst Overview

HIV Testing Machines market outlook remains robust, driven by rising HIV prevalence, growing emphasis on early diagnosis, and expanding access to point-of-care solutions. The market's attractiveness is further bolstered by technological advancements and supportive government initiatives, particularly in emerging economies.

Key Insights6 items

Market Attractiveness: High, with untapped potential in low-income regions and increasing private-sector investments in diagnostic infrastructure.

Competitive Intensity: Moderate, characterized by a mix of established players and niche innovators focusing on rapid, portable testing solutions.

Long-Term Outlook: Positive, with sustained demand projected through 2030 due to global health priorities and aging populations in developed markets.

Innovation Landscape: Dynamic, with trends including AI-integrated diagnostics, mobile testing platforms, and self-testing kits to improve user engagement.

Demand–Supply Balance: Supply is sufficient in high-income regions, but gaps persist in sub-Saharan Africa and South Asia, offering growth opportunities.

Key Risk Factors: Regulatory hurdles, funding uncertainties for public health programs, and potential market saturation in advanced economies.

Strategic partnerships and decentralized testing models will be critical for addressing disparities. Decision-makers should prioritize scalability and adaptability to navigate evolving public health needs.

12 items

1. Executive Summary

2. HIV Testing Machines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global HIV Testing Machines Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global HIV Testing Machines Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global HIV Testing Machines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global HIV Testing Machines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global HIV Testing Machines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global HIV Testing Machines Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global HIV Testing Machines Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global HIV Testing Machines Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global HIV Testing Machines Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global HIV Testing Machines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global HIV Testing Machines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global HIV Testing Machines Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global HIV Testing Machines Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global HIV Testing Machines Market Competition by Key Manufacturers

9.1. Global HIV Testing Machines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global HIV Testing Machines: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Siemens

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Danaher

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Abbott Laboratories

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bio-Rad Laboratories

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. AccuBioTech

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. BioMerieux

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Qiagen

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Meridian Bioscience

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Hologic

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Creative Diagnostics

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global HIV Testing Machines Market

Figure 4: Global HIV Testing Machines Market: Drivers

Figure 5: Global HIV Testing Machines Market: Challenges

Figure 6: Global HIV Testing Machines Market: Trends

Figure 7: Global HIV Testing Machines Market: Opportunity

Figure 8: Global HIV Testing Machines Market: Restraint

Figure 9: Global HIV Testing Machines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global HIV Testing Machines Market Value (USD Million) By Region

Figure 19: Global HIV Testing Machines Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global HIV Testing Machines Market Value (USD Million) By Region

Figure 27: Global HIV Testing Machines Market Share (%) By: Regions (2032)

Figure 28: Global HIV Testing Machines Market Volume (K) By Region

Figure 29: Global HIV Testing Machines Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global HIV Testing Machines Market Value (USD Million) By Region

Figure 37: Global HIV Testing Machines Market Share (%) By: Regions (2032)

Figure 38: Global HIV Testing Machines Market Volume (K) By Region

Figure 39: Global HIV Testing Machines Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global HIV Testing Machines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global HIV Testing Machines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global HIV Testing Machines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global HIV Testing Machines Market Value (USD Million) By Region

Table 14: Global HIV Testing Machines Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global HIV Testing Machines Market Volume (K) By Region

Table 31: Global HIV Testing Machines Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global HIV Testing Machines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global HIV Testing Machines Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global HIV Testing Machines Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Roche Basic Information And Sales Area

Table 52: Roche. Products Portfolio

Table 53: Siemens Basic Information And Sales Area

Table 54: Siemens. Products Portfolio

Table 55: Danaher Basic Information And Sales Area

Table 56: Danaher. Products Portfolio

Table 57: Abbott Laboratories Basic Information And Sales Area

Table 58: Abbott Laboratories. Products Portfolio

Table 59: Bio-Rad Laboratories Basic Information And Sales Area

Table 60: Bio-Rad Laboratories. Products Portfolio

Table 61: AccuBioTech Basic Information And Sales Area

Table 62: AccuBioTech. Products Portfolio

Table 63: BioMerieux Basic Information And Sales Area

Table 64: BioMerieux. Products Portfolio

Table 65: Qiagen Basic Information And Sales Area

Table 66: Qiagen. Products Portfolio

Table 67: Meridian Bioscience Basic Information And Sales Area

Table 68: Meridian Bioscience. Products Portfolio

Table 69: Hologic Basic Information And Sales Area

Table 70: Hologic. Products Portfolio

Table 71: Creative Diagnostics Basic Information And Sales Area

Table 72: Creative Diagnostics. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global HIV Testing Machines Market Value (USD Million) By Region

Table 82: Global HIV Testing Machines Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global HIV Testing Machines Market Volume (K) By Region

Table 99: Global HIV Testing Machines Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

HIV Testing Machines Market Overview

Report Overview

Report Attribute	Details
Market size value in 2025	2.10 billion
Revenue forecast in 2033	3.83 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Siemens; Danaher; Abbott Laboratories; Bio-Rad Laboratories; AccuBioTech; BioMerieux; Qiagen; Meridian Bioscience; Hologic; Creative Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options